French pharma giant Sanofi buys up US mRNA vaccine research firm


French pharmaceutical group Sanofi has announced it is buying US firm Translate Bio, with which it has been working to develop an mRNA Covid jab, for 3.2 billion dollars, as it attempts to make up lost ground in the colossal market for Covid jabs.

Reading articles is for subscribers only. Subscribe now.

France's pharmaceutical giant Sanofi, which has lagged behind rivals in developing new-generation mRNA Covid-19 vaccines, on Tuesday said it has purchased a US firm specialising in the technology, reports FRANCE 24.